Papajík T., Jarošová M., Plachý R., Indrák K.:
B-cell chronic lymphocytic leukaemia
|
53 |
Marcinek J.1, Plank L.2:
biological characterization and histological “grading” of the fibrosis with respect to diagnosis
and prognosis
|
62 |
Starková J.1, Krejčí O.1, Otová B.2, Krejčíková K.1, Hrušák O.3, Starý J.1, Trka J.1:
TEL/AML1 increases
sensitivity of leukemia cells to L-Asparginase by induction of metabolic stress
|
70 |
Kalinová M. 1,2, Mužíková K. 1,2, Šrámková L. 1,2, Starý J. 3, Horák J.4, Trka J. 1,2:
Is WT1 gene hyperexpression
a malignant cells marker?
|
76 |
Gumulec J.1, Kessler P.2, Penka M.3, Klodová D.1, Králová S.1, Brejcha M.1, Wróbel W.1, Šumná E.1, Blatný J.3, Klaricová K.1, Riedlová P.1, Lasota Z.:
Hemorrhagic complications during warfarin therapy
|
83 |
Hromadníková I.1, Žejšková L.1, Doucha J.2, Wagenknecht D.1:
Non-invasive prenatal diagnosis from
maternal peripheral blood is performed on fractionated extracellular fetal DNA with size < 500 bp
|
95 |
Procházková J.1, Procházka M.2, Papajík T.1, Látalová E.2, Hluší A.1, Ľubušký M.2, Neoral Č.3,Geierová M.4, Indrák K.1:
Idiopathic thrombocytopenic purpura in pregnancy refractory to immunosuppressive
treatment – case report
|
100 |
Pelková J.:
Anagrelide in the treatment of thrombocytosis in myeloproliferative disease – case report
|
104 |
